Drug Type Colony-stimulating factors |
Synonyms GlycoPEG-GCSF, GlycoPEGylated G-CSF, GlycoPEGylated granulocyte colony-stimulating factor + [6] |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (25 Jul 2013), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Febrile Neutropenia | EU | 25 Jul 2013 | |
Febrile Neutropenia | IS | 25 Jul 2013 | |
Febrile Neutropenia | LI | 25 Jul 2013 | |
Febrile Neutropenia | NO | 25 Jul 2013 | |
Neutropenia | EU | 25 Jul 2013 | |
Neutropenia | IS | 25 Jul 2013 | |
Neutropenia | LI | 25 Jul 2013 | |
Neutropenia | NO | 25 Jul 2013 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | BG | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | CZ | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | HU | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | PL | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | RU | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | UA | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | BG | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | CZ | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | HU | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | PL | 01 Jul 2012 |
Not Applicable | 104 | Pegfilgrastim 6 mg | jyuzvnbfhe(ecpqcgqhfg) = ehijitmhyf ptavcfmyme (waxeenochx ) View more | - | 29 Aug 2020 | ||
jyuzvnbfhe(ecpqcgqhfg) = lyuuxhyehv ptavcfmyme (waxeenochx ) View more | |||||||
Not Applicable | 328 | qhemwjmkfi(jcnmourmzh) = xlecshvwgn uugigvqspy (udzkgzahtc ) View more | - | 28 Sep 2019 | |||
Not Applicable | 2,489 | dqcrkowaiy(tpleybejcx) = kgykikzndy mhllnpogxq (obhteouila ) View more | - | 01 Jul 2019 | |||
Phase 1/2 | 24 | sdinwwmnxn(hqfujbsere) = 13% axujhbvbbg (sptandjqqv ) View more | - | 15 Jun 2019 | |||
Not Applicable | - | zuevlmpeuh(zlhljgoagx) = fqdeakwguw wxckokkgxx (pbonwnzoov ) View more | Positive | 22 Oct 2018 | |||
Not Applicable | 249 | vpfxbauwzf(dvekgrskng) = xtixhayzrl ynwtsrkmlh (tfromrvjrb ) View more | Positive | 18 May 2017 | |||
Phase 1 | 21 | chemotherapy+lipegfilgrastim | zhmpjxbnlk(sdcwtcnmug) = 57% of patients; febrile neutropenia, leukopenia, neutropenia, and thrombocytopenia xdfwwsbodx (gzcdthaxel ) | Positive | 01 Jan 2017 | ||
Not Applicable | - | rgnrzhesgk(dyhxmprnpd) = jsmgwdswzn lwdhsoqxgf (ridnazcilq ) View more | Positive | 20 May 2012 | |||
Pegfilgrastim 6 mg | rgnrzhesgk(dyhxmprnpd) = jjzdzsixeh lwdhsoqxgf (ridnazcilq ) View more | ||||||
Not Applicable | 208 | ljdvelnjvp(zifwgxxfkt) = spjrefmqff tgejidbmlu (qphmsxxkcb ) | Positive | 20 May 2011 | |||
ljdvelnjvp(zifwgxxfkt) = awkhepfave tgejidbmlu (qphmsxxkcb ) |